MARC record from Internet Archive

LEADER: 03673cam 2200781 a 4500
001 ocm39360949
003 OCoLC
005 20200429221002.0
008 980622s1998 gw a b 001 0 eng
010 $a 98029079
040 $aDLC$beng$cDLC$dOHX$dCOU$dC#P$dSQU$dOCLCQ$dBAKER$dNLGGC$dBTCTA$dYDXCP$dOCLCG$dHEBIS$dZWZ$dBDX$dOCLCO$dNLM$dOCLCF$dOCLCQ
016 7 $a953851915$2DE-101
016 7 $a101607737$2DNLM
020 $a3540646914$q(alk. paper)
020 $a9783540646914$q(alk. paper)
035 $a(OCoLC)39360949
050 00 $aQP905$b.H3 vol. 132$aRM340
060 00 $aW1$bHA51L v.132 1999
060 10 $aQV 190
072 7 $aQP$2lcco
082 00 $a615/.1 s$a615/.718$221
084 $a44.86$2bcl
245 00 $aAntithrombotics /$ccontributors, W. Bell [and others] ; editors, Andrew C.G. Uprichard and Kim P. Gallagher.
260 $aBerlin ;$aNew York :$bSpringer,$c℗♭1999.
300 $axxiii, 485 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aHandbook of experimental pharmacology ;$vv. 132
504 $aIncludes bibliographical references and index.
505 0 $aThe coagulation pathway and antihrombotic strategies -- New developments in the molecular biology of coagulation and fibrinolysis -- Epidemiology of arterial and venous thrombosis -- In vivo models of thrombosis -- Monitoring antithrombotic therapy -- Use of transgenic mice in the study of thrombosis and hemostasis -- Current antiplatelet therapy -- Platelet membrane receptors and signalling pathways: new therapeutic targets -- Heparin and other indirect antithrombin agents -- Low molecular weight heparin -- Parenteral direct antithrombins -- Anticoagulant therapy with warfarin for thrombotic disorders -- Oral thrombin inhibitors: challenges and progress -- Inhibitors of factor Xa -- Inhibitors of tissue factor/factor VIIa -- Natural anticoagulants and their pathways.
650 0 $aFibrinolytic agents.
650 0 $aThrombosis.
650 0 $aBlood$xCoagulation.
650 12 $aFibrinolytic Agents.
650 22 $aThrombosis$xdrug therapy.
650 22 $aBlood Coagulation$xphysiology.
650 7 $aFibrinolytiques.$2fmesh
650 7 $aThrombose$xTraitement me dicamenteux.$2fmesh
650 7 $aCoagulation sanguine$xPhysiologie.$2fmesh
650 7 $aBlood$xCoagulation.$2fast$0(OCoLC)fst00834568
650 7 $aFibrinolytic agents.$2fast$0(OCoLC)fst00923665
650 7 $aThrombosis.$2fast$0(OCoLC)fst01150428
650 17 $aAntitrombotica.$2gtt
650 17 $aAnticoagulantia.$2gtt
650 7 $aSang$xCoagulation.$2ram
650 7 $aThrombose$xChimiothe rapie.$2ram
650 7 $aFibrinolytique.$2ram
650 07 $aAntithrombotikum.$2swd
700 1 $aBell, William Robert,$d1937-
700 1 $aUprichard, Andrew C. G.,$d1957-
700 1 $aGallagher, Kim P.,$d1950-
776 08 $iOnline version:$tAntithrombotics.$dBerlin ; New York : Springer, ℗♭1999$w(OCoLC)645906919
830 0 $aHandbook of experimental pharmacology ;$vv. 132.
938 $aBaker & Taylor$bBKTY$c425.00$d425.00$i3540646914$n0003183530$sactive
938 $aBrodart$bBROD$n52773825$c$325.00
938 $aBaker and Taylor$bBTCP$n98029079
938 $aOtto Harrassowitz$bHARR$nhar000626477
938 $aYBP Library Services$bYANK$n1502955
029 1 $aAU@$b000013967482
029 1 $aHEBIS$b060376139
029 1 $aNLGGC$b174400675
029 1 $aNLM$b101607737
029 1 $aNZ1$b4942993
029 1 $aOHX$bhar000626477
029 1 $aYDXCP$b1502955
994 $aZ0$bP4A
948 $hHELD BY P4A - 108 OTHER HOLDINGS